0
0
57 words
0
Comments
Novavax Inc <a href="https://www.reuters.com/companies/NVAX.O" target="_blank">(NVAX.O)</a> said on Wednesday it will manufacture its COVID-19 vaccine in Canada after the country's health regulator allowed its use in children aged between 12 and 17 years as a…
You are the first to view
https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-make-covid-19-vaccine-shots-canada-2022-12-07/
Create an account or login to join the discussion